Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
European Journal of Biochemistry
|
April 2, 1998
The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule
A E Dear, R L Medcalf
Biochimica Et Biophysica Acta
|
September 27, 2000
The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity
A E Dear, R L Medcalf
FEBS Letters
|
February 3, 1997
Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA
A E Dear, M Costa, R L Medcalf
Pathology
|
January 1, 1996
Malignant pulmonary lymphoid disease: case reports illustrating anatomical pattern of disease as a prognostic marker
A E Dear, D Goldstein, J A Hayman
Internal Medicine Journal
|
October 6, 2012
Clinical-scientific notes
R J Dick, K A Byron, A E Dear
European Journal of Biochemistry
|
October 1, 1996
Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression
A E Dear, Y Shen, M Rüegg, et al.
International Journal of Oncology
|
July 23, 2014
Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies
H B Liu, D Urbanavicius, P Tan, et al.
International Journal of Oncology
|
January 22, 2011
The anti-leukemic effect and molecular mechanisms of novel hydroxamate and benzamide histone deacetylase inhibitors with 5-aza-cytidine
H B Liu, P A Mayes, P Perlmutter, et al.
Biochemical and Biophysical Research Communications
|
July 2, 2005
Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation
H B Liu, Y S Hu, R L Medcalf, et al.
International Journal of Oncology
|
January 17, 2009
The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expression
H B Liu, M T Voso, D Gumiero, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
European Journal of Biochemistry
|
April 2, 1998
The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule
A E Dear, R L Medcalf
Biochimica Et Biophysica Acta
|
September 27, 2000
The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity
A E Dear, R L Medcalf
FEBS Letters
|
February 3, 1997
Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA
A E Dear, M Costa, R L Medcalf
Pathology
|
January 1, 1996
Malignant pulmonary lymphoid disease: case reports illustrating anatomical pattern of disease as a prognostic marker
A E Dear, D Goldstein, J A Hayman
Internal Medicine Journal
|
October 6, 2012
Clinical-scientific notes
R J Dick, K A Byron, A E Dear
European Journal of Biochemistry
|
October 1, 1996
Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression
A E Dear, Y Shen, M Rüegg, et al.
International Journal of Oncology
|
July 23, 2014
Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies
H B Liu, D Urbanavicius, P Tan, et al.
International Journal of Oncology
|
January 22, 2011
The anti-leukemic effect and molecular mechanisms of novel hydroxamate and benzamide histone deacetylase inhibitors with 5-aza-cytidine
H B Liu, P A Mayes, P Perlmutter, et al.
Biochemical and Biophysical Research Communications
|
July 2, 2005
Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation
H B Liu, Y S Hu, R L Medcalf, et al.
International Journal of Oncology
|
January 17, 2009
The anti-leukemic effect of a novel histone deacetylase inhibitor MCT-1 and 5-aza-cytidine involves augmentation of Nur77 and inhibition of MMP-9 expression
H B Liu, M T Voso, D Gumiero, et al.
Page
of 2